Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 47 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
F2
💬1. F2
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer 8件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagu ... | Thrombomodulin alfa
Thrombomodulin alfa
💬1. F2
| Thrombomodulin Alfa | 1件: 85 85 💬1. F2
| ||||||||||||||
| 2 |
F2
💬2. F2
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer 8件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagu ... | Dabigatran etexilate
Dabigatran etexilate
💬2. F2
| Dabigatran etexilate | 2件: 51 51, 75 💬
| ||||||||||||||
| 3 |
F2
💬3. F2
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer 8件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagu ... | Dabigatran
Dabigatran
💬3. F2
| Dabigatran | 5件: 51 51, 75, 85, 91, 124 💬
| ||||||||||||||
| 4 |
F8
💬4. F8
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Desmopressin
Desmopressin
💬4. F8
| Desmopressin | 6件: 6 6, 64, 72, 75, 225, 288 💬
| ||||||||||||||
| 5 |
F9
💬5. F9
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬5. F9
| Emicizumab | 1件: 288 288 💬5. F9
| ||||||||||||||
| 6 |
F10
💬6. F10
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Apixaban
Apixaban
💬6. F10
| Apixaban | 1件: 222 222 💬6. F10
| ||||||||||||||
| 7 |
F10
💬7. F10
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Rivaroxaban
Rivaroxaban
💬7. F10
| Rivaroxaban | 4件: 46 46, 49, 91, 210 💬
| ||||||||||||||
| 8 |
F10
💬8. F10
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Edoxaban
Edoxaban
💬8. F10
| Edoxaban | 2件: 46 46, 88 💬
| ||||||||||||||
| 9 |
F10
💬9. F10
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬9. F10
| Emicizumab | 1件: 288 288 💬9. F10
| ||||||||||||||
| 10 |
FCER1A
💬10. FCER1A
| 4件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Fc epsilon RI signaling pathway, Asthma 4件: Sphingolipid signaling pathway, Phospholipase D signaling pathway, Fc epsilon RI signaling pathw ... | Omalizumab
Omalizumab
💬10. FCER1A
| Omalizumab | 7件: 46 46, 53, 65, 98, 162, 226, 299 💬
|